Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,251.79
+13.280.41%
Number of Gainers:23
Number of Losers:7
Number of Flat:1
PE:- -
High:3,269.98
Open:3,238.34
Low:3,232.35
Close:3,238.51
Volume:317.43M
Turnover:37.84B
Market Cap:6.15T
Float Cap:5.43T

Loading ...

Pentagon Signs 7-Year Deals to Increase Missile Production

Reuters
·
Aug 31

Pentagon Makes 7-Year Agreements with General Dynamics and Lockheed Martin to Triple Pac-3 and Quadruple Thaad Production

THOMSON REUTERS
·
Aug 31

Dick’s Sporting Goods to Join Goldman Sachs Global Consumer and Retail Conference Fireside Chat

Reuters
·
Aug 31

Next up for Tesla's Self-Driving Tech: Potholes

Dow Jones
·
Aug 31

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Aug 31

Foreign Banks Applaud China's Fresh Real Estate Overhaul, Marking the Most Substantial Housing Reform in Nearly Three Decades

Deep News
·
Aug 31

Riot Platforms (RIOT) Gets a Buy from Bernstein

TIPRANKS
·
Aug 31

U.s. Stocks on the Move-Pinterest, Intel, Slb

Reuters
·
Aug 31

The Stock Market Rally is About to Face Its Biggest Test

Dow Jones
·
Aug 31

Bernstein Sticks to Their Hold Rating for MARA Holdings (MARA)

TIPRANKS
·
Aug 31

Moonshot AI seeks up to 30% revenue share from major cloud providers for its Kimi models

Deep News
·
Aug 31

Does Adding Qualcomm’s Akash Palkhiwala to the Board Sharpen Applied Materials’ AI Strategy Narrative (AMAT)?

Simply Wall St.
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

AECOM Named Design Partner for Freeway Project in New Zealand

MT Newswires Live
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31

Model YL rear suspension failures plague owners as Tesla juggles record deliveries with slumping profits

Deep News
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Aug 31

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Aug 31